Navigation Links
ViaCyte Announces Executive Management Changes
Date:8/9/2011

SAN DIEGO, Aug. 9, 2011 /PRNewswire/ -- ViaCyte, Inc. today announced changes to its  executive management team, including the appointment of Allan Robins, Ph.D., as Acting Chief Executive Officer, and the promotion of Kevin D'Amour, Ph.D., to Chief Scientific Officer.

Robins continues to serve as Vice President and Chief Technology Officer, and his appointment as acting CEO follows the departure of President and Chief Executive Officer John West who resigned for personal reasons. West continues his relationship with ViaCyte as a consultant and as a member of its Board of Directors. The Board has initiated a search for a new CEO.

"Allan has successfully led our process development and manufacturing operations since our merger with BresaGen in 2004 and has made a number of significant contributions to ViaCyte's research and technology platform.  We're pleased to have Allan assume this important interim CEO role. We also thank John West for his leadership and for his achievements in extending our company's funding resources," said Fred Middleton, Chairman of ViaCyte.

Prior to ViaCyte, Robins served as Chief Scientific Officer at BresaGen, Inc., the United States subsidiary of BresaGen Limited, an Australian biotechnology company that has since been acquired by Hospira, Inc.  Under Robins' leadership, BresaGen secured significant support from the National Institutes of Health for its stem cell research. Robins received his Ph.D. in molecular biology from the University of Adelaide in Australia and completed postdoctoral work at Cambridge University in England.

"I welcome the opportunity to serve in this expanded role as our forward progress continues," said Robins.  Commenting on D'Amour's promotion, Robins noted:

"Kevin has been essential in the development of our scientific program and is a world renowned stem cell expert.  As CSO, Kevin will lead the alignment of ViaCyte's research strategy with its b
'/>"/>

SOURCE ViaCyte, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Cellular Dynamics Licenses Technology From ViaCyte
2. NeoStem Announces the Receipt of Over $1,700,000 in DOD Funding for its VSEL™ Technology Being Developed to Treat Osteoporosis
3. Dendreon Announces Webcast Presentation at Canaccord Genuity Growth Conference
4. Osteologix Announces Completion of Corporate Consolidation
5. Interleukin Genetics, Inc. Announces Conference Call to Discuss Second Quarter 2011 Results
6. Palatin Announces Commencement of a Phase 1 Trial for Obesity Compound in Collaboration with AstraZeneca
7. Rigel Announces Second Quarter 2011 Financial Results
8. WAVi Co. Announces Collaborative Agreement with SomaLogic, Inc.
9. Vermillion Announces Notice of Allowance for Peripheral Artery Disease (PAD) Patent
10. International Isotopes Inc. Announces Successful International Standards Certification for Manufacture of Its Nuclear Medicine Products and Devices
11. Biocept, Inc. Announces Availability of Its New Breast Cancer Test, OncoCEE-BR™ Utilizing Circulating Tumor Cells (CTCs)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Rootstown, OH (PRWEB) January 22, 2015 Crystal ... announced today that it has received AOAC-PTM Certifications for the ... O111, O121, and O145; collectively referred to as STEC or ... at 1 colony forming unit (cfu) per 325 g of ...
(Date:1/22/2015)... 22, 2015 zFlo Motion , a ... announce an exciting product from a new partner. STT-Systems ... over the past 15 years, with offerings in the optical-motion ... 3D IMU system (inertial measurement unit), iSen, is opening eyes ...
(Date:1/22/2015)... DE (PRWEB) January 22, 2015 Controlled ... Pistoia Alliance, which helps companies check the legal requirements ... to expand to China. , As their international ... are globally adopting software solutions built as a result ...
(Date:1/22/2015)... 22, 2015 Diagenode, Inc., a ... the Bioruptor® and complete solutions for epigenetics research, ... immunoprecipitation, alleviating the need for manual processing. The ... for ChIP of histones or transcription factors and ...
Breaking Biology Technology:Crystal Diagnostics Awarded AOAC-PTM Accreditation for the Rapid Detection of “Big 6” E.coli Food Pathogens 23D Motion Capture Just Got Easy 2Global Compliance Service for Controlled Substances to Expand to China 2Diagenode Launches Unique Semi-Automated Solution for Chromatin Immunoprecipitation 2
... BioTrends Research Group, Inc. finds that with ... (DMA) for the treatment of multiple sclerosis (MS), neurologists anticipate ... month after the launch of Gilenya, trial and uptake of ... to be tempered due to the perception that Extavia is ...
... , Menlo Park, Calif. December 9, 2010 ... and Harvard Medical School have successfully employed single molecule, ... pathogen responsible for the recent deadly cholera epidemic in ... Journal of Medicine, the results provide the first ...
... Dec. 10, 2010 ACCESS PHARMACEUTICALS, INC. ... biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments ... entered into definitive agreements with existing and new accredited investors ... approximately 2.3 million shares of its common stock at a ...
Cached Biology Technology:With the Recent Launch of Novartis's Gilenya, Extavia is Pushed Into the Background of Multiple Sclerosis Treatment One Year After its Launch 2With the Recent Launch of Novartis's Gilenya, Extavia is Pushed Into the Background of Multiple Sclerosis Treatment One Year After its Launch 3Pacific Biosciences and Harvard scientists decode genome of Haitian cholera pathogen 2Pacific Biosciences and Harvard scientists decode genome of Haitian cholera pathogen 3Access Pharmaceuticals Raises $6.0 Million In Registered Direct Offering 2Access Pharmaceuticals Raises $6.0 Million In Registered Direct Offering 3
(Date:1/22/2015)... FindBiometrics, the leading source of biometrics industry news, interviews and ... "When we launched FindBiometrics 12 years ago the ... founder and CEO of FindBiometrics. "Now it,s maturing very quickly. ... players on a very broad scale.  We are known for ...
(Date:1/22/2015)... Jan. 15, 2015  BellBrook Labs, a leader in ... the launch of a TR-FRET (time resolved Forster ... UDP Assay, a high throughput screening assay for ... will allow for sensitive detection of hundreds of ...
(Date:1/22/2015)... NEW YORK and POINT ROBERTS, Washington ... global news source covering leading sectors including technology and tech ... Personal Privacy marketplace featuring master pickpocket and security consultant ... wallet is stolen and talks about the Wocket™ biometric smart ...
Breaking Biology News(10 mins):Identity Industry Leading Publication Debuts New Look As Biometrics Hit Mainstream 2BellBrook Labs Launches a High Throughput Screening Assay for Glycosyltransferases with TR-FRET Readout 2Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 2Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 3
... gene therapy can nearly eliminate arthritis pain, and significantly ... a study published today in the journal Arthritis and ... are the first genetically engineered to develop osteoarthritis like ... more likely to develop the disease, the authors said. ...
... their brains are more adept at learning than their normal ... has changed, a team led by researchers at UT Southwestern ... today in the online edition of the journal Nature ... brain, which might serve in humans as a target for ...
... ants in the rainforests of Central and South America conduct ... some ants use their bodies to plug potholes in the ... so that prey can be delivered to the developing young ... the nest by a trail of forager traffic, along which ...
Cached Biology News:Experimental gene therapy 'abolishes' arthritis pain and lessens joint damage 2Experimental gene therapy 'abolishes' arthritis pain and lessens joint damage 3Experimental gene therapy 'abolishes' arthritis pain and lessens joint damage 4'Smart' mice teach scientists about learning process, brain disorders 2Ants show us how to make super-highways 2
14-3-3 tau Antibody Shipping Temperature: HOT Storage Temperature: -20C...
Rabbit polyclonal to Lck (phospho Y192) ( Abpromise for all tested applications). entrezGeneID: 3932 SwissProtID: P06239...
Goat polyclonal to Ephrin B2 ( Abpromise for all tested applications). entrezGeneID: 1948 SwissProtID: P52799...
Mouse monoclonal [RL13] to LAP1 ( Abpromise for all tested applications). SwissProtID: Q96NW7...
Biology Products: